Keros Therapeutics KROS Peer Comparison

NASDAQ KROS
$11.17 -0.14 (-1.24%)
As of: Sep 10, 2026 · 3:59 PM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

Keros Therapeutics, Inc. (KROS) is the 194th largest of 300 Biotechnology companies by market capitalisation, at 220.97 Mn, behind Surrozen, Inc./DE at 227.43 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 206.44 Bn 23.61 5.42 192.45 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 179.97 Bn -62.17 5.91 176.79 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 130.57 Bn 29.64 10.37 122.72 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 81.63 Bn 18.86 5.25 73.63 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 60.34 Bn 35.18 11.55 55.16 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 54.37 Bn -17.25 24.40 49.23 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 33.07 Bn 42.69 6.88 29.76 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 31.84 Bn 38.15 3.17 30.55 Bn
9 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 29.49 Bn -19.87 2,700.12 29.49 Bn
10 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.67 Bn -31.61 24.33 26.51 Bn
11 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 23.29 Bn -13.66 7.53 9.63 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 15.83 Bn 18.25 11.16 14.88 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.52 Bn -48.66 12.09 14.68 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.19 Bn -20.51 19.90 13.47 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.23 Bn — — 12.54 Bn
16 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.67 Bn 173.64 3.72 11.80 Bn
17 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.55 Bn 30.34 7.54 12.32 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 11.87 Bn -43.61 17.73 10.27 Bn
19 AAVXF Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
21 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.87 Bn -25.87 — 9.11 Bn
22 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.56 Bn 86.56 33.90 9.56 Bn
23 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.21 Bn -43.38 10.53 7.15 Bn
24 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn -8.05 — 8.51 Bn
25 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn -8.16 48.86 7.74 Bn
26 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn 17.74 9.80 7.16 Bn
27 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.82 Bn -14.52 — 7.82 Bn
28 GIFLF Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.49 Bn -41.86 — 7.49 Bn
30 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.25 Bn -17.96 — 7.25 Bn
31 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.01 Bn -33.34 29.22 6.68 Bn
32 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.38 Bn -7.41 10.32 5.94 Bn
33 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.34 Bn -28.31 1,018.73 6.34 Bn
34 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.33 Bn -707.29 4,550.66 6.33 Bn
35 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.93 Bn 73.54 7.05 5.41 Bn
36 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.86 Bn -16.17 — 5.86 Bn
37 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.83 Bn -15.77 — 5.83 Bn
38 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn 29.43 19.98 4.45 Bn
39 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn — — 4.04 Bn
40 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn -31.93 1,119.47 5.44 Bn
41 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.59 Bn 14.62 5.54 3.36 Bn
42 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.97 Bn -17.31 — 4.97 Bn
43 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.68 Bn -21.39 — 4.68 Bn
44 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.01 Bn -7.84 1,112.24 4.01 Bn
45 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 3.91 Bn — — 3.51 Bn
46 TLPPF Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
47 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn -13.44 371.20 3.84 Bn
48 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.74 Bn -6.99 — 3.74 Bn
49 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -29.39 — 3.57 Bn
50 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn -34.24 65.12 2.49 Bn
51 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.45 Bn -15.66 14.72 2.62 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.27 Bn -7.11 27.96 2.57 Bn
53 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.19 Bn -19.40 48.28 3.19 Bn
54 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn 107.18 6.58 2.82 Bn
55 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn -5.89 — 3.04 Bn
56 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -9.64 18,760.43 2.96 Bn
57 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -27.84 — 2.90 Bn
58 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.87 Bn -8.41 78.07 2.43 Bn
59 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.87 Bn -14.24 — 2.87 Bn
60 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.83 Bn -10.46 593.06 2.31 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.69 Bn -14.30 5.98 1.98 Bn
62 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.55 Bn -78.59 — 2.55 Bn
63 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.42 Bn -6.03 — 2.42 Bn
64 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.39 Bn -7.90 45.94 2.39 Bn
65 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
66 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -19.72 42.93 1.66 Bn
67 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -5.84 32.87 2.34 Bn
68 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.21 — 1.86 Bn
69 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 12.88 4.18 2.01 Bn
70 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.13 Bn -34.18 11.28 2.02 Bn
71 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.11 Bn -5.47 3.94 1.75 Bn
72 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn 0.17 0.33 0.58 Bn
73 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.07 Bn -15.06 103.30 2.07 Bn
74 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -8.50 — 2.06 Bn
75 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn -4.84 20.26 1.99 Bn
76 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.95 Bn -4.68 1,945.12 1.95 Bn
77 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -9.33 70.26 1.65 Bn
78 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -12.89 52.06 1.66 Bn
79 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn -3.28 — 1.66 Bn
80 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn -4.87 — 1.92 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.84 Bn -11.27 17.54 1.46 Bn
82 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -7.05 5.85 1.77 Bn
83 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -13.10 1,344.64 1.75 Bn
84 GLPGF Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
85 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -94.63 3.98 0.83 Bn
86 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -121.81 17.20 1.70 Bn
87 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.69 Bn -3.25 30.72 1.13 Bn
88 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -9.22 6.62 1.12 Bn
89 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -26.69 — 1.30 Bn
90 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -6.28 — 1.11 Bn
91 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -10.40 527.33 1.60 Bn
92 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -66.19 7.94 1.29 Bn
93 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
94 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -8.46 — 1.57 Bn
95 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.56 Bn -10.48 — 1.56 Bn
96 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -6.19 3.70 0.81 Bn
97 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.52 Bn -181.75 884.05 1.52 Bn
98 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -9.11 20.12 1.21 Bn
99 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -3.18 2.05 1.18 Bn
100 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -13.85 73.44 1.47 Bn
101 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -9.43 50.55 0.82 Bn
102 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -8.37 — 1.37 Bn
103 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -16.21 — 1.36 Bn
104 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn -9.67 — 1.35 Bn
105 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn 78.67 34.95 1.34 Bn
106 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -8.28 — 1.30 Bn
107 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -6.37 — 1.30 Bn
108 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -10.72 831.75 1.10 Bn
109 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.32 — 1.28 Bn
110 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -5.24 152.36 0.77 Bn
111 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn -1.32 — 1.21 Bn
112 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -24.95 — 0.98 Bn
113 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -26.90 2.98 1.06 Bn
114 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -7.61 — 1.17 Bn
115 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.13 Bn -19.65 — 1.13 Bn
116 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.11 Bn -10.85 46.36 1.11 Bn
117 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 6.64 5.57 0.92 Bn
118 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -118.02 — 0.98 Bn
119 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -3.67 — 0.44 Bn
120 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -4.70 14.54 0.58 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -67.71 — 0.89 Bn
122 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn -13.59 3.75 0.61 Bn
123 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.90 Bn -16.10 1.99 0.61 Bn
124 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.81 8.44 0.49 Bn
125 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 2.72 3.16 0.78 Bn
126 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.83 Bn -4.06 — 0.83 Bn
127 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -14.79 798.14 0.80 Bn
128 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -9.87 95.55 0.79 Bn
129 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -7.46 — 0.75 Bn
130 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -120.02 2.24 0.58 Bn
131 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.73 Bn -9.69 40.13 0.40 Bn
132 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -5.87 — 0.68 Bn
133 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.66 Bn -6.06 — 0.60 Bn
134 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 2.95 1.68 0.57 Bn
135 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -16.17 1,021.92 0.56 Bn
136 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.26 — 0.61 Bn
137 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -3.69 579.05 0.43 Bn
138 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -338,119.55 — 0.59 Bn
139 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -12.17 — 0.59 Bn
140 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 461.94 7.68 0.25 Bn
141 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 60.69 1.78 0.00 Bn
142 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.68 3.39 0.42 Bn
143 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -9.08 — 0.55 Bn
144 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -6.34 — 0.54 Bn
145 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.48 13.21 0.46 Bn
146 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -4.35 — 0.50 Bn
147 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
148 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.66 8.59 0.18 Bn
149 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.56 2.02 0.37 Bn
150 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -19.56 — 0.44 Bn
151 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 14.81 2.40 0.39 Bn
152 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -6.80 20.42 0.18 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.48 — 0.46 Bn
154 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.37 — 0.45 Bn
155 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.40 12.72 0.19 Bn
156 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -2.23 — 0.22 Bn
157 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -5.32 — 0.43 Bn
158 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.04 — 0.42 Bn
159 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.27 — 0.24 Bn
160 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.19 13.57 0.21 Bn
161 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.12 37.37 0.39 Bn
162 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.68 — 0.38 Bn
163 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -3.99 37.80 0.18 Bn
164 HMDCF HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
165 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -5.85 5.66 0.18 Bn
166 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -1.19 131.41 0.19 Bn
167 DMAC DiaMedica Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -10.63 — 0.35 Bn
168 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -4.22 — 0.34 Bn
169 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -2.80 — 0.34 Bn
170 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.41 — 0.32 Bn
171 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -4.81 8.60 0.25 Bn
172 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.80 — 0.32 Bn
173 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -1.95 99.01 0.31 Bn
174 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.59 3.27 0.13 Bn
175 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 3.10 2.14 0.28 Bn
176 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -15.17 — 0.27 Bn
177 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -3.97 — 0.27 Bn
178 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -5.01 12.26 0.27 Bn
179 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.63 57.67 0.27 Bn
180 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.41 4.38 0.27 Bn
181 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -3.18 — 0.26 Bn
182 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -9.17 — 0.26 Bn
183 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.06 — 0.26 Bn
184 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -15.71 1.51 0.14 Bn
185 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.00 59.36 0.25 Bn
186 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.94 4.40 0.09 Bn
187 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -17.63 — 0.13 Bn
188 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 61.72 — 0.14 Bn
189 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -7.26 — 0.24 Bn
190 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -2.71 17.13 0.06 Bn
191 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.79 97.04 0.12 Bn
192 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.49 3.09 0.14 Bn
193 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.73 19.76 0.23 Bn
194 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.45 6.73 -0.04 Bn
195 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.12 — 0.22 Bn
196 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 10.31 2.71 0.18 Bn
197 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -9.78 — 0.22 Bn
198 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.91 — 0.21 Bn
199 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.58 4.10 0.10 Bn
200 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -3.16 15.05 0.18 Bn
201 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.27 — 0.21 Bn
202 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.97 — 0.21 Bn
203 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -4.15 9.53 0.07 Bn
204 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 1.15 — 0.20 Bn
205 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -13.14 32.66 0.19 Bn
206 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -3.05 — 0.17 Bn
207 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.47 — 0.19 Bn
208 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.78 8.01 0.16 Bn
209 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.33 — 0.18 Bn
210 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.56 2.72 0.04 Bn
211 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.16 2.27 -0.05 Bn
212 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.06 60.09 0.17 Bn
213 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -11.24 — 0.15 Bn
214 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.62 — -0.01 Bn
215 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.42 190.84 0.16 Bn
216 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -116.03 — 0.16 Bn
217 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -5.03 13.16 0.12 Bn
218 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -4.69 31.57 0.15 Bn
219 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.87 — 0.15 Bn
220 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.03 Bn
221 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.23 — 0.14 Bn
222 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -9.75 — 0.13 Bn
223 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,766.90 -0.04 Bn
224 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.74 — 0.13 Bn
225 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -1.88 43.97 0.13 Bn
226 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.22 — 0.13 Bn
227 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -6.07 37.25 0.10 Bn
228 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.86 1,274.74 0.13 Bn
229 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.90 — 0.07 Bn
230 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -4.51 122.85 0.12 Bn
231 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -6.55 — 0.11 Bn
232 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -2.34 — 0.00 Bn
233 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.19 — 0.11 Bn
234 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -4.76 13.24 0.06 Bn
235 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.35 — 0.10 Bn
236 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn — — -0.06 Bn
237 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.77 — 0.09 Bn
238 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 2.10 148.17 0.10 Bn
239 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.03 60.89 0.09 Bn
240 TLPH Talphera, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -6.58 92,898.09 0.09 Bn
241 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.03 — 0.09 Bn
242 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.47 — 0.08 Bn
243 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.83 — 0.09 Bn
244 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -118.64 — 0.09 Bn
245 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.15 — 0.08 Bn
246 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 2.69 — 0.08 Bn
247 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.98 140.17 0.08 Bn
248 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 9.82 1.19 -0.11 Bn
249 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
250 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -2.96 — 0.05 Bn
251 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.64 — 0.08 Bn
252 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -4.00 — 0.07 Bn
253 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 — 0.07 Bn
254 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.48 — 0.07 Bn
255 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.60 — 0.07 Bn
256 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.82 — 0.07 Bn
257 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 11.31 1.39 0.01 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -6.98 0.41 0.02 Bn
259 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -3.05 2.86 -0.06 Bn
260 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.78 14.68 0.02 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.06 — 0.05 Bn
262 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.24 — 0.05 Bn
263 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.60 26.49 0.05 Bn
264 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -2.64 1,418.00 0.05 Bn
265 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.27 — 0.05 Bn
266 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.39 5.09 0.05 Bn
267 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.40 2.25 0.05 Bn
268 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.50 3.65 0.05 Bn
269 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.67 294.15 -0.01 Bn
270 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
271 BDRX Biodexa Pharmaceuticals Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -6.38 — 0.03 Bn
272 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -4.28 — 0.04 Bn
273 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 3.60 1.16 0.04 Bn
274 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.04 — 0.02 Bn
275 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.43 311.32 0.02 Bn
276 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.01 77.85 0.04 Bn
277 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.59 — 0.04 Bn
278 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.66 — 0.03 Bn
279 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.86 — 0.04 Bn
280 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.75 — 0.03 Bn
281 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.72 4.79 0.03 Bn
282 ALP Alpha Compute Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.02 0.19 0.03 Bn
283 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.12 0.94 0.02 Bn
284 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.17 4.27 0.03 Bn
285 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.49 — 0.03 Bn
286 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
287 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -6.19 0.38 0.03 Bn
288 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.31 37.43 0.03 Bn
289 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.23 — 0.03 Bn
290 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.46 — 0.03 Bn
291 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -23.02 — 0.03 Bn
292 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -12.26 93.50 0.03 Bn
293 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.61 — 0.03 Bn
294 YDESW YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
295 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.30 869.19 0.02 Bn
296 RDPTF Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.28 97.58 0.02 Bn
297 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.70 — 0.02 Bn
298 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.44 — 0.02 Bn
299 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.10 — 0.02 Bn
300 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.32 2.68 0.01 Bn